JP2024539088A5 - - Google Patents
Info
- Publication number
- JP2024539088A5 JP2024539088A5 JP2024523401A JP2024523401A JP2024539088A5 JP 2024539088 A5 JP2024539088 A5 JP 2024539088A5 JP 2024523401 A JP2024523401 A JP 2024523401A JP 2024523401 A JP2024523401 A JP 2024523401A JP 2024539088 A5 JP2024539088 A5 JP 2024539088A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell population
- percent
- tcr
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163257805P | 2021-10-20 | 2021-10-20 | |
| US63/257,805 | 2021-10-20 | ||
| PCT/US2022/046745 WO2023069322A1 (en) | 2021-10-20 | 2022-10-14 | Methods and materials for expanding tumor infiltrating gamma-delta t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539088A JP2024539088A (ja) | 2024-10-28 |
| JP2024539088A5 true JP2024539088A5 (cg-RX-API-DMAC7.html) | 2025-10-09 |
Family
ID=85980818
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523401A Pending JP2024539088A (ja) | 2021-10-20 | 2022-10-14 | 腫瘍浸潤ガンマ-デルタt細胞を拡大するための方法及び材料 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230117388A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4419118A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024539088A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3235971A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023069322A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025082502A1 (en) * | 2023-10-18 | 2025-04-24 | Nanjing Legend Biotech Co., Ltd. | Pan t cells and methods of manufacturing of the same |
| ES3034332B2 (es) * | 2025-05-21 | 2026-05-08 | Univ Madrid Complutense | Método de expansión selectiva in vitro y adquisición de fenotipo residente en tejido decélulas T Yo Vo1+ derivadas de sangre periférica |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2336302T3 (es) * | 2000-04-03 | 2010-04-12 | Therapure Biopharma Inc. | Produccion de celulas ttcr gamma delta. |
| US9907820B2 (en) * | 2013-10-25 | 2018-03-06 | Board Of Regents, The University Of Texas System | Polyclonal gamma delta T cells for immunotherapy |
| GB201506423D0 (en) * | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| RU2756247C2 (ru) * | 2014-11-17 | 2021-09-28 | Эдисет Био, Инк. | Генетически модифицированные гамма дельта т-клетки |
| CN118421557A (zh) * | 2016-05-12 | 2024-08-02 | 阿迪塞特治疗公司 | 选择性扩增γδT细胞群的方法及其组合物 |
| GB201707048D0 (en) * | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
| WO2018229163A1 (en) * | 2017-06-14 | 2018-12-20 | King's College London | Methods of activating v delta 2 negative gamma delta t cells |
| CA3082818A1 (en) * | 2017-11-15 | 2019-05-23 | Adicet Bio Inc. | Methods for selective expansion of .delta.3 .gamma..delta. t-cell populations and compositions thereof |
| EP3927353A4 (en) * | 2019-02-24 | 2022-11-23 | Gamida-Cell Ltd. | METHOD OF ECOTAXY AND RETENTION OF GAMMADELTA T LYMPHOCYTES, OPTIONALLY WITH NATURAL KILLER CELLS, ALLOWING THE GENERATION OF CELLULAR COMPOSITIONS FOR USE IN THERAPY |
| CA3148588A1 (en) * | 2019-08-16 | 2021-02-25 | GammaDelta Therapeutics Limited | Ex vivo gamma delta t cell populations |
-
2022
- 2022-10-14 WO PCT/US2022/046745 patent/WO2023069322A1/en not_active Ceased
- 2022-10-14 JP JP2024523401A patent/JP2024539088A/ja active Pending
- 2022-10-14 US US17/966,444 patent/US20230117388A1/en active Pending
- 2022-10-14 EP EP22884294.4A patent/EP4419118A4/en active Pending
- 2022-10-14 CA CA3235971A patent/CA3235971A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020518289A5 (cg-RX-API-DMAC7.html) | ||
| Consentius et al. | Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo? | |
| DE102017127984B4 (de) | Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen | |
| Bozzano et al. | Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity | |
| Turka et al. | Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking | |
| Chen et al. | Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice | |
| Wei et al. | Functional tooth restoration by allogeneic mesenchymal stem cell-based bio-root regeneration in swine | |
| Chamley et al. | Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture | |
| Gielen et al. | Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression | |
| Liu et al. | CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells | |
| Merola et al. | Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression | |
| SHER et al. | Acceptance of allogeneic fibroblasts in skin equivalent transplants | |
| Mendt et al. | Metabolic reprogramming of GMP grade cord tissue derived mesenchymal stem cells enhances their suppressive potential in GVHD | |
| Yang et al. | Amelioration of acute graft‐versus‐host disease by adoptive transfer of ex vivo expanded human cord blood CD4+ CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model | |
| Naha | Temperature sensitive conditional mutants of monkey kidney cells | |
| Moretta et al. | Assignment of human natural killer (NK)‐like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK‐sensitive target cells via distinct recognition structures | |
| US8076134B2 (en) | CD4+CD25− T cells and Tr1-like regulatory T cells | |
| Jewett et al. | Tumor microenvironment may shape the function and phenotype of NK cells through the induction of split anergy and generation of regulatory NK cells | |
| Cohen et al. | Rejection of tumor allografts by mouse spleen cells sensitized in vitro | |
| Jeon et al. | The immunomodulatory effect of adipose-derived stem cells in xenograft transplantation model | |
| JP2023514788A5 (cg-RX-API-DMAC7.html) | ||
| Johnson et al. | Natural killer cells in skin: a unique opportunity to better characterize the many facets of an overlooked secondary lymphoid organ | |
| Rygaard | SKIN GRAFTS IN NUDE MICE: 2. Rat Skin Grafts in Nude Mice of Three Genetic Backgrounds (BALB/c, C3H, C57/BL). The Effects after Preparation by Thymus Grafts | |
| Pastille et al. | Exploring the role of innate lymphoid cells in the periodontium: insights into immunological dynamics during orthodontic tooth movement | |
| US20200095549A1 (en) | Method for inducing regulatory t cell |